News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
New Medtronic, Inc. Pacemaker Delayed Over FDA Issues
September 29, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Star Tribune -- Medtronic is working to resolve issues that came up in a warning letter and are holding up final approval of several new devices.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Government
Senate Summons Kennedy Again Amid CDC Leadership Turmoil
August 29, 2025
·
3 min read
·
Tristan Manalac
Vaccines
FDA Clears Updated COVID-19 Shots From Pfizer, Moderna, Novavax—But With Restrictions
August 28, 2025
·
2 min read
·
Tristan Manalac
Policy
Monarez Fired From Top CDC Spot Following Friction Over New COVID-19 Vaccine Policy
August 28, 2025
·
3 min read
·
Heather McKenzie
Regulatory
The US Is Losing Its Biopharma Edge, Writes Former FDA Commissioner
August 27, 2025
·
3 min read
·
Dan Samorodnitsky